Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$58.87 - $83.05 $111,853 - $157,795
-1,900 Reduced 2.85%
64,800 $5.2 Million
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $3.41 Million - $4.55 Million
66,700 New
66,700 $4.15 Million
Q2 2023

Aug 11, 2023

SELL
$82.41 - $99.65 $6.82 Million - $8.25 Million
-82,770 Reduced 99.96%
30 $2,000
Q1 2023

May 10, 2023

SELL
$47.76 - $82.86 $109,848 - $190,578
-2,300 Reduced 2.7%
82,800 $6.84 Million
Q4 2022

Feb 13, 2023

BUY
$48.76 - $77.67 $87,768 - $139,806
1,800 Added 2.16%
85,100 $4.34 Million
Q3 2022

Nov 10, 2022

SELL
$61.42 - $86.29 $98,272 - $138,064
-1,600 Reduced 1.88%
83,300 $5.86 Million
Q2 2022

Aug 12, 2022

BUY
$55.54 - $72.65 $4.72 Million - $6.17 Million
84,900 New
84,900 $5.61 Million
Q3 2020

Nov 13, 2020

SELL
$11.98 - $16.34 $1.45 Million - $1.97 Million
-120,800 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$9.11 - $20.05 $10,932 - $24,060
-1,200 Reduced 0.98%
120,800 $1.54 Million
Q4 2019

Feb 12, 2020

BUY
$18.47 - $24.03 $302,908 - $394,092
16,400 Added 15.53%
122,000 $2.5 Million
Q3 2019

Nov 13, 2019

SELL
$21.01 - $28.94 $571,472 - $787,168
-27,200 Reduced 20.48%
105,600 $2.65 Million
Q2 2019

Aug 02, 2019

BUY
$23.33 - $28.3 $681,236 - $826,360
29,200 Added 28.19%
132,800 $3.76 Million
Q4 2018

Feb 12, 2019

BUY
$12.68 - $19.01 $532,560 - $798,420
42,000 Added 68.18%
103,600 $1.62 Million
Q4 2017

Feb 13, 2018

BUY
$17.4 - $23.4 $87,000 - $117,000
5,000 Added 8.83%
61,600 $1.26 Million
Q3 2017

Nov 13, 2017

SELL
$15.5 - $19.15 $201,500 - $248,949
-13,000 Reduced 18.68%
56,600 $1.01 Million
Q2 2017

Aug 14, 2017

BUY
N/A
69,600
69,600 $1.23 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.